Integra LifeSciences Holdings Corp has completed acquiring the DuraSeal product line from Irish medical device manufacturer Covidien. The financial terms of the said deal were not disclosed, according to Healio.
A company press release said Integra will provide details on the financial effects of the transaction during the firm's 2013 financial results conference on February 25, the report stated.
Robert Davis, Integra's president of US neurosurgery division, said of the deal: "The acquisition of the DuraSeal product line offers us a great opportunity to drive our neurosurgery growth strategy, aimed at providing a broader set of solutions for surgical procedures in the head. The neurosurgery product portfolio will now have products in both dural grafting and the different indication of dural sealing. DuraSeal is the first-to-market dural sealant approved for use in both the cranium and spine."
Integra is a company that provides innovative solutions in neurosurgery, reconstructive, general surgery, spine, orthopedic surgeries. The firm was founded in 1989 and is currently based in Plainsboro, New Jersey. The medical device firm employs more than 3,500 workers globally, according to Integra's company website.
Join the Conversation